SEARCH BY

Issuer directory Issuer directory
KEYWORDS
COMPANIES / ISIN
TYPE OF INFORMATION
INDUSTRY

Start search  ADVANCED SEARCH

COMPARTMENTS / INDICES

France
America
Asia
Oceania
Africa
Europe

MSI NEWS

FEEDS

My RSS My Google Microsoft Live My Yahoo

COMPANY SEARCH RESULT

ROCHE: Click to view the issuer\'s details

Last update : 16/08/2018  >View issuer details

2020.07.14 | 07:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Roche collaborates with Blueprint Medicines to bring a new treatment to people with RET-altered cancers - HTML (w)

2020.07.13 | 07:03 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce New data from phase IIIb study reinforces safety profile of Roche’s Hemlibra in people with haemophilia A - HTML (w)

2020.07.13 | 07:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Roche provides update on Phase III study of Tecentriq in women with advanced stage ovarian cancer - HTML (w)

2020.06.13 | 08:30 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Positive phase III results for Venclexta/Venclyxto combination in acute myeloid leukaemia presented at EHA 2020 - HTML (w)

2020.06.02 | 07:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce FDA approves Roche’s Tecentriq in combination with Avastin for people with the most common form of liver cancer - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 332